Florida Cancer Specialists Foundation

Hodgkin lymphoma, named after Dr. Thomas Hodgkin, is a cancer that affects the lymphatic system which makes up part of the body’s immune system.

Medical oncologist Manish R Patel, MD, a member of the clinical research team at Florida Cancer Specialists & Research Institute , LLC (FCS), first-authored a study examining dose escalation of an oral complete estrogen receptor (ER) antagonist (CERAN)/selective ER degrader (SERD) in cases of advanced and/or metastatic estrogen receptor-positive, HER2-negative breast cancer.

Medical oncologist James Reeves, MD, a member of the clinical research team at Florida Cancer Specialists & Research Institute (FCS), is co-author of a study that examined the use and effectiveness of niraparib, a targeted therapy drug, to reduce the recurrence of HER2-negative, BRCA mutated breast cancer.

The inaugural Metastatic Breast Cancer Heroes™ winners were announced by CURE Media Group, recognizing individuals making a difference in the lives of those affected by metastatic breast cancer. Among the three winners is Florida Cancer Specialists & Research Institute, LLC (FCS) oncology nurse Brandi Riber, RN, based in Fort Myers.